Clinical Trial

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 24, 2023 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
HCC is one of most common causes of cancer-related death in the world due to lately diagnosis by typical hallmarks which rely on completed arterialization. So it is important to earlier diagnose and treat hypovascular early HCC(eHCC). The aim of this study is to evaluate the efficacy and safety of microwave ablation for early HCC, also to explore the feasibility of EOB-MRI (Gd-EOB-DTPA enhanced MRI) guided ablation.
Trial Details
NCT Number NCT06096896
Lead Sponsor Shandong Provincial Hospital
Conditions Early Hepatocellular Carcinoma
Enrollment 334 participants
Start Date 2023-08-30
Primary Completion 2025-09-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2023-10-24